Literature DB >> 7612563

Collagen types I and III in giant papillae of vernal keratoconjunctivitis.

A Leonardi1, G Abatangelo, R Cortivo, A G Secchi.   

Abstract

AIMS: The objective of this study was to investigate alterations in conjunctival collagen and proteoglycans in the conjunctival giant papillae of patients with vernal keratoconjunctivitis (VKC).
METHODS: Tissue samples from tarsal giant papillae of seven eyes from five patients with VKC, and five tarsal conjunctival samples from five normal patients were obtained. Tissues were processed and stained with haematoxylin and eosin, Van Gieson, trichromic Mallory, toluidine blue, Alcian blue, and alkaline Giemsa. Collagen extraction was performed in acetic acid and pepsin, total collagen was quantified using hydroxy-proline levels, and collagen types I and III were analysed by gel electrophoresis (SDS-PAGE). Proteoglycans were quantified using uronic acid levels.
RESULTS: Histological evaluation showed a significant increase of mast cells in the epithelium (0/mm2 v 147/mm2, p < 0.01) and in the stroma (5.1/mm2 v 80/mm2, p < 0.01) of VKC patients. Collagen fibres were thicker and arranged irregularly, with the total amount significantly increased. Owing to an increased percentage of type III collagen, the ratio of collagen types I to III was decreased. Proteoglycans were also reduced in VKC samples.
CONCLUSION: The well known morphological abnormalities observed in VKC correspond to alterations in the ratio between collagens and proteoglycans, and between different types of collagen. The greatly increased number of mast cells found in these tissues suggests an active role for these cells in the abnormal connective tissue metabolism observed in VKC.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7612563      PMCID: PMC505140          DOI: 10.1136/bjo.79.5.482

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  18 in total

Review 1.  Vernal keratoconjunctivitis.

Authors:  R J Buckley
Journal:  Int Ophthalmol Clin       Date:  1988

2.  Heterogeneity of collagens in rabbit cornea: type III collagen.

Authors:  C Cintron; B S Hong; H I Covington; E J Macarak
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-05       Impact factor: 4.799

3.  Human conjunctival mast cells: distribution of MCT and MCTC in vernal conjunctivitis and giant papillary conjunctivitis.

Authors:  A M Irani; S I Butrus; K F Tabbara; L B Schwartz
Journal:  J Allergy Clin Immunol       Date:  1990-07       Impact factor: 10.793

4.  Subepithelial fibrosis in the bronchi of asthmatics.

Authors:  W R Roche; R Beasley; J H Williams; S T Holgate
Journal:  Lancet       Date:  1989-03-11       Impact factor: 79.321

Review 5.  Mast cells, fibroblasts, and fibrosis. New clues to the riddle of mast cells.

Authors:  K L Choi; H N Claman
Journal:  Immunol Res       Date:  1987       Impact factor: 2.829

6.  Eosinophils and endomyocardial fibrosis.

Authors:  C J Spry; J Davies; P C Tai
Journal:  Contrib Microbiol Immunol       Date:  1983

7.  Phagocytosis of mast cell granules by cultured fibroblasts.

Authors:  P V Subba Rao; M M Friedman; F M Atkins; D D Metcalfe
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

8.  Mast cell numbers and staining characteristics in the normal and allergic human conjunctiva.

Authors:  S J Morgan; J H Williams; A F Walls; M K Church; S T Holgate; J I McGill
Journal:  J Allergy Clin Immunol       Date:  1991-01       Impact factor: 10.793

9.  Conjunctival basophil hypersensitivity in the guinea pig.

Authors:  M R Allansmith; A H Cornell-Bell; R S Baird; K J Bloch; P W Askenase
Journal:  J Allergy Clin Immunol       Date:  1986-11       Impact factor: 10.793

10.  Effect of histamine on proliferation of normal human adult lung fibroblasts.

Authors:  M Jordana; A D Befus; M T Newhouse; J Bienenstock; J Gauldie
Journal:  Thorax       Date:  1988-07       Impact factor: 9.139

View more
  2 in total

1.  Effect of lodoxamide and disodium cromoglycate on tear eosinophil cationic protein in vernal keratoconjunctivitis.

Authors:  A Leonardi; F Borghesan; A Avarello; M Plebani; A G Secchi
Journal:  Br J Ophthalmol       Date:  1997-01       Impact factor: 4.638

Review 2.  Use of cyclosporine A and tacrolimus in treatment of vernal keratoconjunctivitis.

Authors:  Pakit Vichyanond; Panida Kosrirukvongs
Journal:  Curr Allergy Asthma Rep       Date:  2013-06       Impact factor: 4.806

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.